Inicio > Term: siplizumab
siplizumab
A monoclonal antibody that is being studied in the treatment of certain lymphoproliferative disorders and psoriasis. Also called MEDI-507.
- Parte del discurso: noun
- Industria/ámbito: Asistencia sanitaria
- Categoría: Tratamiento del cáncer
- Company: U.S. HHS
0
Creador
- Lionel M
- 100% positive feedback